For decades, animals have served as the default for drug testing, but the biological divide between species is proving costly. Currently, only about 10 percent of drugs that enter human trials receive ...

GVSU is financing a bond of up to $139 million, a decision applauded by university leaders and decried by some faculty ...

The dual-satellite platform uses Sentinel-2 and Landsat-8 data to detect farm water contamination in real time, qualifying ...

1. Long-Context Reasoning: Recursive language models (RLMs) now enable reasoning over effectively unlimited context, ...

The global dental laboratory services market is expected to register a compound annual growth rate (CAGR) of approximately 7% ...

NYU Grossman School of Medicine’s Vilcek Institute of Graduate Biomedical Sciences offers PhD training in biomedical imaging.

Indian American professor to oversee peer-review process for one of the world’s most selective computer networking conferences ...

From vegetation scans to 360-degree smoke detectors, new tools are trying to shine a light on the most dangerously dark areas ...

In an interview with Technology Networks, Dr. Daniel Reker discusses how machine learning is improving data-scarce areas of drug discovery.

Artificial intelligence is no longer just about breakthroughs in labs or pumping billions of dollars into data centres — it’s in our hospitals, courtrooms, classrooms, and on the battlefield.

The Quantum Computing Center in downtown Los Alamos will bring together up to three dozen quantum researchers from across the ...